Lanja has completed the Series A funding of hundred millions CNY

Healthcare Author: Violet Chen Sep 11, 2023 10:04 PM (GMT+8)

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.


Lanja is a comprehensive solution provider for full airway visualization, committed to the research and development and production of innovative visualization airway tools, focusing on accelerating the transformation of intelligent visualization technology, promoting interdisciplinary integration and exchange, and contributing to smart healthcare.

According to Lanja, the world's first airway assessment information management system based on artificial intelligence and big data has been officially launched, and related products will be officially launched to the market in 2023, serving clinical applications. From 2023 to 2025, Lanja Medical plans to complete the registration and mass production of over ten airway management products, fully meeting the usage needs of different types of users.

According to IDC, the global market size for airway management consumables was approximately USD 432.8 billion in 2022, and it is expected to exceed USD 500 billion by 2023. With the continuous progress of medical technology, the growth of chronic diseases, and the intensification of population aging, the market for airway management consumables is driving growth.

In addition to Lanja, many companies are competing in the airway management consumables market, such as Wellead (维力医疗), Medris (迈德莱睿医疗) and UE Medical (浙江优亿医疗) in China, Teleflex in the United States, Ambu in Denmark, Medtronic in Ireland and Smiths Medical in the United Kingdom. 

Shazhou Kechuang and Phoenix Technologies stated: “the domestic airway management tool industry continues to grow, and breakthroughs have been made in the research and development of domestic airway management tools. Domestic brands that focus on product innovation, high cost-effectiveness, and high-quality services are facing development opportunities. The Yuansheng Airway Assessment System of Lanja Medical integrates multiple technological advantages, including autonomous algorithms, autonomous data collection modules, and programming tools, making it easy for doctors to use; In addition, the founding team of the company has been deeply involved in the field of airway management for many years, with extensive channel resources and rich experience in product commercialization. With the support of capital, Lanja Medical will accelerate its development, continuously pursue innovation and excellence.”

This round of financing for Lanja was exclusively invested by Shazhou Kechuang (沙洲科创基金) and Phoenix Technologies (凤凰科技). This round of funds will mainly be used for the next stage of development of Lanja Medical.